Valuation: Teva Pharmaceutical Industries Limited

Market Cap 43.03B 0 36.88B 34.5B 31.54B 59.52B 4,121B 60.16B 408B 159B 2,069B 162B 158B 6,846B P/E 2026 *
49.5x
P/E 2027 * 20.3x
Enterprise Value 54.91B 0 47.06B 44.02B 40.25B 75.95B 5,258B 76.76B 521B 203B 2,640B 206B 202B 8,736B EV / Sales 2026 *
3.31x
EV / Sales 2027 * 2.98x
Free-Float
88.59%
Yield 2026 *
-
Yield 2027 * -
1 day+0.64%
1 week+2.59%
Current month+2.02%
1 month+15.76%
3 months+10.46%
6 months+4.62%
Current year+9.91%
1 week 10,850
Extreme 10850
11,240
1 month 9,450
Extreme 9450
11,240
Current year 8,860
Extreme 8860
11,350
1 year 5,990
Extreme 5990
11,350
3 years 3,250
Extreme 3250
11,350
5 years 2,383
Extreme 2383
11,350
10 years 2,175
Extreme 2175
19,900
Manager TitleAgeSince
Chief Executive Officer 57 31/12/2022
Director of Finance/CFO 53 21/12/2019
Chief Operating Officer 52 02/06/2024
Director TitleAgeSince
Director/Board Member 69 31/12/2008
Chairman 78 05/02/2017
Director/Board Member 65 31/08/2015
Change 5-day change 1-year change 3-year change Capi.($)
+0.64%+2.59% - - 43.51B
-0.67%+5.39%+75.21%+127.54% 1,119B
+1.04%+4.07%+52.29%+65.39% 651B
-0.17%+5.67%+25.60%+80.40% 468B
-1.38%+4.02%+41.64%+42.38% 374B
-0.52%+2.72%+24.32%+41.06% 302B
-1.06%+4.76%+1.19%+12.65% 259B
+1.03%+5.83%+51.11%+72.96% 238B
-0.53%+2.34%-17.77%-53.66% 208B
+0.42%+5.63%+27.86%+92.24% 181B
Average -0.12%+4.81%+31.27%+53.44% 422.21B
Weighted average by Cap. -0.22%+4.95%+43.93%+72.99%

Financials

2026 *2027 *
Net sales 16.58B 0 14.21B 13.29B 12.15B 22.94B 1,588B 23.18B 157B 61.17B 797B 62.26B 60.91B 2,638B 17.3B 0 14.83B 13.87B 12.68B 23.94B 1,657B 24.19B 164B 63.83B 832B 64.97B 63.57B 2,753B
Net income 1.14B 0 977M 914M 836M 1.58B 109B 1.59B 10.82B 4.21B 54.83B 4.28B 4.19B 181B 2.34B 0 2B 1.87B 1.71B 3.23B 224B 3.27B 22.17B 8.62B 112B 8.77B 8.58B 372B
Net Debt 11.88B 0 10.18B 9.52B 8.71B 16.43B 1,137B 16.6B 113B 43.81B 571B 44.6B 43.63B 1,890B 8.61B 0 7.38B 6.9B 6.31B 11.91B 825B 12.04B 81.69B 31.76B 414B 32.33B 31.63B 1,370B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Date Price Change Volume
24/08/26 ILA 11,090.00 +0.64% 727,266
21/08/26 ILA 11,020.00 -0.72% 285,212
20/08/26 ILA 11,100.00 -0.98% 625,182
19/08/26 ILA 11,210.00 +1.17% 937,718
18/08/26 ILA 11,080.00 +2.50% 750,535
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
36.93USD
Average target price
41.40USD
Spread / Average Target
+12.10%

Quarterly revenue - Rate of surprise